Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11363-11369
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11363
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11363
Table 4 Classification of groups according to standard deviation of Tacrolimus concentration, death rate and related side effects in respective categories
| Group | 1 | 2 | 3 |
| SD interval | 0-2 | 2-4 | > 4 |
| Total number | 21 | 118 | 96 |
| Number of death | 7 | 18 | 22 |
| Cause of death | |||
| MODS | 4 | 4 | 3 |
| Tumor recurrence | 2 | 7 | 13 |
| Graft loss | 0 | 2 | 1 |
| Others | 1 | 5 | 5 |
| Rejection | 1 | 21 | 16 |
| Infection | 5 | 25 | 25 |
| Renal insufficiency | 0 | 6 | 1 |
| Tumor recurrence | 3 | 14 | 19 |
| Metabolic disorder | 2 | 20 | 12 |
- Citation: Jia JJ, Lin BY, He JJ, Geng L, Kadel D, Wang L, Yu DD, Shen T, Yang Z, Ye YF, Zhou L, Zheng SS. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation. World J Gastroenterol 2014; 20(32): 11363-11369
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11363.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11363